Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc. (ABOS)

Market is closed
News
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2024 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2024 Earnings Call Transcript

Operator: Hello, and thank you for standing by. Welcome to Acumen Pharmaceuticals Q2 2024 conference call and webcast. At this time, all participants are in a listen-only mode.

Keep Reading →

August 14th, 2024 - News Transcripts

Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?

Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?

We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the hedge funds using the latest sentiment data.

Keep Reading →

June 21st, 2024 - Hedge Funds News Stock Analysis

7 Best Halal Stocks To Buy Now (Debt Free)

7 Best Halal Stocks To Buy Now (Debt Free)

Islamic equity investing, also known as Halal investing, has gained significant traction recently as Muslim investors seek to align their financial decisions with their religious beliefs.

Keep Reading →

June 21st, 2024 - Hedge Funds News Stock Analysis

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2024 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to Acumen Pharmaceuticals First Quarter 2024 Conference Call and Webcast.

Keep Reading →

May 15th, 2024 - News Transcripts

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

13 Best Penny Stocks to Buy According to Billionaire Ken Griffin

In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin.

Keep Reading →

April 8th, 2024 - Hedge Funds Lists

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode.

Keep Reading →

March 27th, 2024 - News Transcripts

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharma Third Quarter 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode.

Keep Reading →

November 14th, 2023 - News Transcripts

5 Healthcare Stocks with Insider Buying

5 Healthcare Stocks with Insider Buying

Apogee Therapeutics, Inc.

Keep Reading →

August 17th, 2023 - Hedge Funds Insider Trading News

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q2 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Acumen Pharmaceuticals Second Quarter 2023 Update Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 13th, 2023 - News Transcripts

Hedge Fund and Insider Trading News: Saba Capital Management, Balyasny Asset Management, Alumni Capital Management, Acumen Pharmaceuticals, Inc. (ABOS), and More

Hedge Fund and Insider Trading News: Saba Capital Management, Balyasny Asset Management, Alumni Capital Management, Acumen Pharmaceuticals, Inc. (ABOS), and More

Balyasny Asset Management, a US-based hedge fund, has named Tarek Rizk as its head for the Mena market.

Keep Reading →

July 28th, 2023 - Hedge Funds Insider Trading

Insider Monkey Quarterly Strategy
+275.3% Insider Monkey Quarterly Strategy
+125.2% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through May 20, 2024)